Core Laboratories - Public Comps and Valuation Multiples

Core Laboratories Overview

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

Founded

1936

HQ

Employees

3.5K+

Website

corelab.com

Sectors

Energy Equipment
Fossil Fuels

Financials

LTM Revenue $515M

LTM EBITDA $72.5M

EV

$679M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Core Laboratories Financials

As of September 2025, Core Laboratories reported last 12-month revenue of $515M and EBITDA of $72.5M.

In the same period, Core Laboratories generated $102M in LTM gross profit and $36.8M in net income.

See Core Laboratories valuation multiples based on analyst estimates

Core Laboratories P&L

In the most recent fiscal year, Core Laboratories reported revenue of $524M and EBITDA of $73.5M.

Core Laboratories expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Core Laboratories valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$515M	XXX	$524M	XXX	XXX	XXX
Gross Profit	$102M	XXX	$88.4M	XXX	XXX	XXX
Gross Margin	20%	XXX	17%	XXX	XXX	XXX
EBITDA	$72.5M	XXX	$73.5M	XXX	XXX	XXX
EBITDA Margin	14%	XXX	14%	XXX	XXX	XXX
EBIT	$57.9M	XXX	$49.8M	XXX	XXX	XXX
EBIT Margin	11%	XXX	10%	XXX	XXX	XXX
Net Profit	$36.8M	XXX	$31.4M	XXX	XXX	XXX
Net Margin	7%	XXX	6%	XXX	XXX	XXX
Net Debt	XXX	XXX	$107M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Core Laboratories including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $515M. EBITDA for the last twelve months was $72.5M. In the most recent fiscal year, Core Laboratories achieved $524M in revenue and $73.5M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$515M	Analyst estimates available to subscribers	$524M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$102M	Analyst estimates available to subscribers	$88.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	19.8% gross margin	Analyst estimates available to subscribers	16.9% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$72.5M	Analyst estimates available to subscribers	$73.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	14.1% EBITDA margin	Analyst estimates available to subscribers	14.0% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$57.9M	Analyst estimates available to subscribers	$49.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	11.2% EBIT margin	Analyst estimates available to subscribers	9.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$36.8M	Analyst estimates available to subscribers	$31.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	7.1% net profit margin	Analyst estimates available to subscribers	6.0% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$107M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Core Laboratories

This financial data table provides comprehensive performance metrics for Core Laboratories, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Core Laboratories generated $515M in revenue over the last twelve months.
The company achieved $72.5M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $102M.
Net income over the last twelve months reached $36.8M.

Fiscal Year Performance

In the most recent fiscal year, Core Laboratories reported $524M in total revenue.
Fiscal year EBITDA was $73.5M.
The company maintained a gross profit margin of 16.9% in the most recent fiscal year.
EBITDA margin for the fiscal year was 14.0%.
Net profit margin reached 6.0% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Core Laboratories. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Core Laboratories Stock Performance

Core Laboratories has current market cap of $532M, and EV of $679M.

Market Cap Evolution

Core Laboratories Stock Data

As of October 17, 2025, Core Laboratories's stock price is $11.

See Core Laboratories trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$679M	$532M	XXX	XXX	XXX	XXX	$0.73

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Core Laboratories Valuation Multiples

Core Laboratories's trades at 1.3x EV/Revenue multiple, and 9.2x EV/EBITDA.

See valuation multiples for Core Laboratories and 15K+ public comps

Core Laboratories Financial Valuation Multiples

As of October 17, 2025, Core Laboratories has market cap of $532M and EV of $679M.

Equity research analysts estimate Core Laboratories's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Core Laboratories has a P/E ratio of 14.5x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$532M	XXX	$532M	XXX	XXX	XXX
EV (current)	$679M	XXX	$679M	XXX	XXX	XXX
EV/Revenue	1.3x	XXX	1.3x	XXX	XXX	XXX
EV/EBITDA	9.4x	XXX	9.2x	XXX	XXX	XXX
EV/EBIT	11.7x	XXX	13.6x	XXX	XXX	XXX
EV/Gross Profit	6.7x	XXX	n/a	XXX	XXX	XXX
P/E	14.5x	XXX	16.9x	XXX	XXX	XXX
EV/FCF	18.4x	XXX	15.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Core Laboratories Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Core Laboratories Margins & Growth Rates

Core Laboratories's last 12 month revenue growth is 1%

Core Laboratories's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $11K for the same period.

Core Laboratories's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Core Laboratories's rule of X is 17% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Core Laboratories and other 15K+ public comps

Core Laboratories Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	1%	XXX	0%	XXX	XXX	XXX
EBITDA Margin	14%	XXX	14%	XXX	XXX	XXX
EBITDA Growth	1%	XXX	0%	XXX	XXX	XXX
Rule of 40	15%	XXX	15%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	17%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$11K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	7%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial